Archived explainer. For the current picture see today's MMED page.
MINIMED GROUP INC (MMED) is up +6.61% in the latest session. Our newswire has captured 1 story on MMED across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 50/100).
MiniMed Group Inc (MMED) shares rose 6.61% to $16.93 on July 20, 2026, driven by the company's announcement of an upcoming earnings report. The stock's move reflects investor anticipation ahead of the scheduled release of fiscal year 2027 first-quarter financial results. The news, which was the only story covering the stock in the last 36 hours, appears to have drawn attention to the company's near-term visibility.
MiniMed announced that it expects to report its first-quarter financial results for fiscal year 2027 on September 1, 2026. The company, which operates as a global leader in diabetes technology, has not yet released details about the performance of the quarter but has provided a timeline for its earnings disclosure. This announcement comes amid a broader market environment where health care stocks have seen intraday movement, with MiniMed among those showing upward momentum. The stock's rise coincides with a recent Wells Fargo rating that maintains an Overweight stance on the company, albeit with a lowered price target to $22.
Despite the stock's recent rise, MiniMed remains unprofitable with a trailing twelve-month (TTM) earnings per share (EPS) of -1.30. The company's revenue has grown by 14.3% TTM, but its net margin remains negative at -10.7%. The stock currently trades within its 52-week range of $10.65 to $19.05, with a market capitalization of $4.8 billion. The 30-day average sentiment score stands at 56 out of 100, while the 7-day average has declined to 50, indicating a recent shift in investor sentiment.
Investors should focus on MiniMed's scheduled earnings report on September 1, 2026, for further insight into the company's financial performance and strategic direction. The report will be a key data point for assessing the company's progress and could influence near-term stock movement.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
NORTHRIDGE, Calif., July 20, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026. A...
More on MMED: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier MMED move explainers: 2026-07-20